133 related articles for article (PubMed ID: 7982082)
1. Effects of chronic intraventricular nerve growth factor treatment on vasoactive intestinal peptide and neuropeptide Y levels in the hippocampal formation and cerebral cortex following fimbrial transections.
Lapchak PA; Araujo DM
Brain Res; 1994 Aug; 654(1):1-7. PubMed ID: 7982082
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic alterations of neuropeptide Y, vasoactive intestinal peptide and choline acetyltransferase in rat cultured chromaffin cells as effected by nerve growth factor and glucocorticoid.
Morimoto M; Morita N; Ichikawa T; Kawata M
Arch Histol Cytol; 1996 Aug; 59(3):205-18. PubMed ID: 8874753
[TBL] [Abstract][Full Text] [Related]
3. Regulation of hippocampal muscarinic receptor function by chronic nerve growth factor treatment in adult rats with fimbrial transections.
Lapchak PA; Araujo DM; Hefti F
Neuroscience; 1993 Mar; 53(2):379-94. PubMed ID: 8388084
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic basic fibroblast growth factor administration to rats with partial fimbrial transections on presynaptic cholinergic parameters and muscarinic receptors in the hippocampus: comparison with nerve growth factor.
Araujo DM; Lapchak PA; Hefti F
J Neurochem; 1993 Sep; 61(3):899-910. PubMed ID: 8360689
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological stimulation reveals recombinant human nerve growth factor-induced increases of in vivo hippocampal cholinergic function measured in rats with partial fimbrial transections.
Lapchak PA; Jenden DJ; Hefti F
Neuroscience; 1992 Oct; 50(4):847-56. PubMed ID: 1448201
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant human nerve growth factor on presynaptic cholinergic function in rat hippocampal slices following partial septohippocampal lesions: measures of [3H]acetylcholine synthesis, [3H]acetylcholine release and choline acetyltransferase activity.
Lapchak PA; Hefti F
Neuroscience; 1991; 42(3):639-49. PubMed ID: 1956513
[TBL] [Abstract][Full Text] [Related]
7. Emerging pharmacology of nerve growth factor.
Lapchak PA; Hefti F
Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):851-60. PubMed ID: 1763196
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic nerve growth factor treatment on hippocampal [3H]cytisine/nicotinic binding sites and presynaptic nicotinic receptor function following fimbrial transections.
Lapchak PA; Araujo DM; Hefti F
Neuroscience; 1994 May; 60(2):293-8. PubMed ID: 8072684
[TBL] [Abstract][Full Text] [Related]
9. Responses of young and aged rat CNS to partial cholinergic immunolesions and NGF treatment.
Wörtwein G; Yu J; Toliver-Kinsky T; Perez-Polo JR
J Neurosci Res; 1998 May; 52(3):322-33. PubMed ID: 9590440
[TBL] [Abstract][Full Text] [Related]
10. Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions.
Hefti F; Dravid A; Hartikka J
Brain Res; 1984 Feb; 293(2):305-11. PubMed ID: 6697222
[TBL] [Abstract][Full Text] [Related]
11. Single-dose and chronic corticosterone treatment alters c-Fos or FosB immunoreactivity in the rat cerebral cortex.
Szakács R; Fazekas I; Mihály A; Krisztin-Péva B; Juhász A; Janka Z
Acta Histochem; 2010 Mar; 112(2):147-60. PubMed ID: 19100597
[TBL] [Abstract][Full Text] [Related]
12. Expression of neurotrophin and trk receptor genes in adult rats with fimbria transections: effect of intraventricular nerve growth factor and brain-derived neurotrophic factor administration.
Venero JL; Knüsel B; Beck KD; Hefti F
Neuroscience; 1994 Apr; 59(4):797-815. PubMed ID: 8058122
[TBL] [Abstract][Full Text] [Related]
13. Nerve growth factor (NGF) augments cortical and hippocampal cholinergic functioning after p75NGF receptor-mediated deafferentation but impairs inhibitory avoidance and induces fear-related behaviors.
Winkler J; Ramirez GA; Thal LJ; Waite JJ
J Neurosci; 2000 Jan; 20(2):834-44. PubMed ID: 10632613
[TBL] [Abstract][Full Text] [Related]
14. Effect of nerve growth factor on the lesioned septohippocampal cholinergic system of aged rats.
Yunshao H; Zhibin Y; Yici C
Brain Res; 1991 Jun; 552(1):159-63. PubMed ID: 1655166
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic regulation of vasoactive intestinal peptide content and release in rat frontal cortex and hippocampus.
Lapchak PA; Beaudet A
J Neurochem; 1990 Oct; 55(4):1340-5. PubMed ID: 2398362
[TBL] [Abstract][Full Text] [Related]
16. Lesions of the laterodorsal tegmental nucleus alter the cholinergic innervation and neuropeptide Y expression in the medial prefrontal cortex and nucleus accumbens.
Pereira PA; Vilela M; Sousa S; Neves J; Paula-Barbosa MM; Madeira MD
Neuroscience; 2015 Jan; 284():707-718. PubMed ID: 25451286
[TBL] [Abstract][Full Text] [Related]
17. BDNF and NGF treatment in lesioned rats: effects on cholinergic function and weight gain.
Lapchak PA; Hefti F
Neuroreport; 1992 May; 3(5):405-8. PubMed ID: 1633277
[TBL] [Abstract][Full Text] [Related]
18. Light and electron microscopic immunocytochemical analysis of the neurovascular relationships of choline acetyltransferase and vasoactive intestinal polypeptide nerve terminals in the rat cerebral cortex.
Chédotal A; Umbriaco D; Descarries L; Hartman BK; Hamel E
J Comp Neurol; 1994 May; 343(1):57-71. PubMed ID: 8027437
[TBL] [Abstract][Full Text] [Related]
19. Nerve growth factor increases cortical choline acetyltransferase-positive fiber staining without affecting cortical cholinergic neurons.
Dekker AJ; Thal LJ
Brain Res; 1993 Jan; 601(1-2):329-32. PubMed ID: 8431782
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y co-exists with vasoactive intestinal polypeptide and acetylcholine in parasympathetic cerebrovascular nerves originating in the sphenopalatine, otic, and internal carotid ganglia of the rat.
Suzuki N; Hardebo JE; Kåhrström J; Owman C
Neuroscience; 1990; 36(2):507-19. PubMed ID: 2215932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
